Hyun-Soo Kim
Algemeen Directeur bij PHARMICELL CO., LTD.
Vermogen: 28 M $ op 30-04-2024
Profiel
Hyun-Soo Kim is currently the Chief Executive Officer and Director at Pharmicell Co., Ltd.
He previously worked as Co-CEO, Director, Head-Research & Development at FCB Twelve Co., Ltd.
from 2009 to 2011, and as Chief Executive Officer & Director at FCB-Pharmicell Co., Ltd.
from 2010 to 2011.
He completed his undergraduate degree at Yonsei University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PHARMICELL CO., LTD
10.89% | 29-02-2024 | 6 535 247 ( 10.89% ) | 28 M $ | 30-04-2024 |
Actieve functies van Hyun-Soo Kim
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARMICELL CO., LTD. | Algemeen Directeur | 19-08-2009 |
Eerdere bekende functies van Hyun-Soo Kim
| Bedrijven | Functie | Einde |
|---|---|---|
FCB Twelve Co., Ltd.
 FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables FCB Twelve Co., Ltd. is engaged in manufacturing, distributing, and selling cell therapeutic drugs and apparels. It operates in two segments: Biotechnology and Fashion. The Biotechnology Segment offers stem cell therapeutic drugs, adult stem cell banking service, and stem cell skin care solution. The Fashion Segment offers garments and other fashion accessories under three brands such as basic by GV2, studio yume, and le body lingerie. It also provides hospital management consulting, resort amenities and services, as well as technology transfer. The company was founded on August 20, 1968 and is headquartered in Seoul, South Korea. | President | 06-10-2011 |
FCB-Pharmicell Co., Ltd.
 FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services FCB-Pharmicell Co., Ltd. develops adult cell stem therapy. It also provides testing services for cell drugs. It has an operating centre in Europe. The company was founded by Kim Hyoo-soo and is headquartered in Seongnam, Korea. | President | 27-06-2011 |
Opleiding van Hyun-Soo Kim
| Yonsei University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHARMICELL CO., LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
FCB-Pharmicell Co., Ltd.
FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services FCB-Pharmicell Co., Ltd. develops adult cell stem therapy. It also provides testing services for cell drugs. It has an operating centre in Europe. The company was founded by Kim Hyoo-soo and is headquartered in Seongnam, Korea. | Commercial Services |
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables FCB Twelve Co., Ltd. is engaged in manufacturing, distributing, and selling cell therapeutic drugs and apparels. It operates in two segments: Biotechnology and Fashion. The Biotechnology Segment offers stem cell therapeutic drugs, adult stem cell banking service, and stem cell skin care solution. The Fashion Segment offers garments and other fashion accessories under three brands such as basic by GV2, studio yume, and le body lingerie. It also provides hospital management consulting, resort amenities and services, as well as technology transfer. The company was founded on August 20, 1968 and is headquartered in Seoul, South Korea. | Consumer Non-Durables |
